269 related articles for article (PubMed ID: 28676328)
1. CD8
Martinez-Escala ME; Kantor RW; Cices A; Zhou XA; Kaplan JB; Pro B; Choi J; Guitart J
J Am Acad Dermatol; 2017 Sep; 77(3):489-496. PubMed ID: 28676328
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and course of CD8+ cytotoxic variant of mycosis fungoides: a case series of seven patients.
Nikolaou VA; Papadavid E; Katsambas A; Stratigos AJ; Marinos L; Anagnostou D; Antoniou C
Br J Dermatol; 2009 Oct; 161(4):826-30. PubMed ID: 19558552
[TBL] [Abstract][Full Text] [Related]
3. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides.
Hodak E; David M; Maron L; Aviram A; Kaganovsky E; Feinmesser M
J Am Acad Dermatol; 2006 Aug; 55(2):276-84. PubMed ID: 16844512
[TBL] [Abstract][Full Text] [Related]
4. A case-control study of clinicopathologic features, prognosis, and therapeutic responses in patients with granulomatous mycosis fungoides.
Li JY; Pulitzer MP; Myskowski PL; Dusza SW; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2013 Sep; 69(3):366-74. PubMed ID: 23685027
[TBL] [Abstract][Full Text] [Related]
5. Hyperpigmented mycosis fungoides: an unusual variant of cutaneous T-cell lymphoma with a frequent CD8+ phenotype.
Pavlovsky L; Mimouni D; Amitay-Laish I; Feinmesser M; David M; Hodak E
J Am Acad Dermatol; 2012 Jul; 67(1):69-75. PubMed ID: 21982059
[TBL] [Abstract][Full Text] [Related]
6. Clinical presentation, immunopathology, and treatment of juvenile-onset mycosis fungoides: a case series of 34 patients.
Boulos S; Vaid R; Aladily TN; Ivan DS; Talpur R; Duvic M
J Am Acad Dermatol; 2014 Dec; 71(6):1117-26. PubMed ID: 25264240
[TBL] [Abstract][Full Text] [Related]
7. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement.
Hodak E; Amitay-Laish I; Feinmesser M; Davidovici B; David M; Zvulunov A; Pavlotsky F; Yaniv I; Avrahami G; Ben-Amitai D
J Am Acad Dermatol; 2014 Jun; 70(6):993-1001. PubMed ID: 24629999
[TBL] [Abstract][Full Text] [Related]
8. Influence of the phenotype on mycosis fungoides prognosis, a retrospective cohort study of 160 patients.
Jaque A; Mereniuk A; Walsh S; Shear NH; Sade S; Zagorski B; Alhusayen R
Int J Dermatol; 2019 Aug; 58(8):933-939. PubMed ID: 30761533
[TBL] [Abstract][Full Text] [Related]
9. [Mycosis fungoides in children and adolescents: a report of six cases with predominantly hypopigmentation, along with a literature review].
Rizzo FA; Vilar EG; Pantaleão L; Fonseca EC; Magrin PF; Henrique-Xavier M; Rochael MC
Dermatol Online J; 2012 Mar; 18(3):5. PubMed ID: 22483516
[TBL] [Abstract][Full Text] [Related]
10. Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas.
Quaglino P; Pimpinelli N; Berti E; Calzavara-Pinton P; Alfonso Lombardo G; Rupoli S; Alaibac M; Bottoni U; Carbone A; Fava P; Fimiani M; Mamusa AM; Titli S; Zinzani PL; Bernengo MG;
Cancer; 2012 Dec; 118(23):5830-9. PubMed ID: 22674564
[TBL] [Abstract][Full Text] [Related]
11. Poikilodermatous mycosis fungoides: a study of its clinicopathological, immunophenotypic, and prognostic features.
Abbott RA; Sahni D; Robson A; Agar N; Whittaker S; Scarisbrick JJ
J Am Acad Dermatol; 2011 Aug; 65(2):313-319. PubMed ID: 21529998
[TBL] [Abstract][Full Text] [Related]
12. Double-positive CD4/CD8 mycosis fungoides: a rarely reported immunohistochemical profile.
Tournier E; Laurent C; Thomas M; Meyer N; Viraben R; Brousset P; Lamant L
J Cutan Pathol; 2014 Jan; 41(1):58-62. PubMed ID: 24134789
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
[TBL] [Abstract][Full Text] [Related]
14. CD8+ T cells in cutaneous T-cell lymphoma: expression of cytotoxic proteins, Fas Ligand, and killing inhibitory receptors and their relationship with clinical behavior.
Vermeer MH; van Doorn R; Dukers D; Bekkenk MW; Meijer CJ; Willemze R
J Clin Oncol; 2001 Dec; 19(23):4322-9. PubMed ID: 11731515
[TBL] [Abstract][Full Text] [Related]
15. Mycosis fungoides in patients under 20 years of age: report of 7 cases, review of the literature and study of the clinical course.
Quaglino P; Zaccagna A; Verrone A; Dardano F; Bernengo MG
Dermatology; 1999; 199(1):8-14. PubMed ID: 10449950
[TBL] [Abstract][Full Text] [Related]
16. Retrospective Analysis of Prognostic Factors in 187 Cases of Transformed Mycosis Fungoides.
Talpur R; Sui D; Gangar P; Dabaja BS; Duvic M
Clin Lymphoma Myeloma Leuk; 2016 Jan; 16(1):49-56. PubMed ID: 26702474
[TBL] [Abstract][Full Text] [Related]
17. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
[TBL] [Abstract][Full Text] [Related]
18. Mycosis Fungoides: Experience in a Pediatric Hospital.
Cervini AB; Torres-Huamani AN; Sanchez-La-Rosa C; Galluzzo L; Solernou V; Digiorge J; Rubio P
Actas Dermosifiliogr; 2017; 108(6):564-570. PubMed ID: 28279399
[TBL] [Abstract][Full Text] [Related]
19. CD8-positive granulomatous mycosis fungoides: a case report with review of the literature.
Ishida M; Hotta M; Takikita-Suzuki M; Kojima F; Okabe H
J Cutan Pathol; 2010 Oct; 37(10):1072-6. PubMed ID: 20579213
[TBL] [Abstract][Full Text] [Related]
20. Transformed mycosis fungoides: clinicopathological features and outcome.
Barberio E; Thomas L; Skowron F; Balme B; Dalle S
Br J Dermatol; 2007 Aug; 157(2):284-9. PubMed ID: 17573879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
